Matthew’s Recent Stories
Nation Jan 13As omicron rages, COVID-19 pill stymied by shortages
Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections.
Health Dec 23FDA authorizes Merck’s pill against COVID-19
The Food and Drug Administration authorization of Merck's molnupiravir comes one day after the agency cleared a competing drug from Pfizer.
Health Dec 22Pfizer pill becomes first home COVID-19 treatment authorized in the U.S.
The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that could overwhelm hospitals.
Health Dec 19Omicron may sideline two leading drugs against COVID-19
As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the…
Health Dec 16U.S. regulators say abortion pill no longer has to be picked up in person
Earlier this year the FDA stopped enforcing the in-person dispending requirement because of the pandemic. Under Thursday's decision the agency will permanently drop the rule.
Politics Dec 14WATCH: Senate hearing on the nomination of Robert Califf as commissioner of FDA
President Joe Biden’s pick to lead the Food and Drug Administration deftly parried questions on crises ranging from the COVID pandemic to the opioid epidemic.
Health Dec 14Pfizer confirms COVID pill’s results, effectiveness against omicron
The company also confirmed Tuesday that the pill delivered on promising early results in reducing COVID-19 hospitalizations and deaths.
Nation Dec 09FDA expands Pfizer COVID booster, opens extra dose to age 16
The U.S. and many other nations already urge adults to get a booster to pump up their immunity months after initial vaccination.
Health Dec 08U.S. approves new COVID-19 antibody drug for high-risk patients
The drug could benefit cancer patients, organ transplant recipients and people with severe allergies to vaccinations.
Health Nov 30FDA panel review final hurdle for Merck’s COVID-19 pill
U.S. health advisers are reviewing Merck's closely watched COVID-19 pill, which could become the first easy-to-use drug for American patients.